Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients

Background Nivolumab is an anti-PD1 antibody that has dramatically improved metastatic melanoma patients’ outcomes. Nevertheless, many patients are resistant to PD-1 inhibition, occasionally experiencing severe off-target immune toxicity. In addition, no robust and reproducible biomarkers have yet b...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Galati, Domenico, Zanotta, Serena, Capone, Mariaelena, Madonna, Gabriele, Mallardo, Domenico, Romanelli, Marilena, Simeone, Ester, Festino, Lucia, Sparano, Francesca, Azzaro, Rosa, De Filippi Rosaria, Pinto, Antonio, Paulos, Chrystal M., Ascierto, Paolo Antonio
Format:	Dataset
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!